Vanguard Personalized Indexing Management’s MaxCyte MXCT Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.2K	Buy	+18,793	New	+$17.5K	﹤0.01%	2142

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Vanguard Personalized Indexing Management's MXCT Position: Q1 2026 in Review

Vanguard Personalized Indexing Management opened a new position in MaxCyte (MXCT) in Q1 2026: 18,793 shares worth $13.2K. The stake represents ﹤0.01% of the portfolio and ranks #2142 among its holdings.

130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Vanguard Personalized Indexing Management held 18,793 shares of MaxCyte worth $13.2K as of Q1 2026.
MaxCyte was a new Vanguard Personalized Indexing Management position in Q1 2026.
MaxCyte made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #2142 holding.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.